Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: Relation to apolipoprotein E polymorphism

Neurology

Volumn 46, Issue 2, 1996, Pages 413-419

  Lehtovirta, M ^a   Soininen, H ^a   Helisalmi, S ^b   Mannermaa, A ^b   Helkala, E L ^a   Hartikainen, P ^a   Hanninen T ^a   Ryynanen M ^b   Riekkinen Sr , P J ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CHROMOSOME 14; CHROMOSOME POLYMORPHISM; COGNITIVE DEFECT; FAMILIAL DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBRILLARY TANGLE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; VERBAL MEMORY;

EID: 0029940649     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.2.413     Document Type: Article

References (65)

1. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985; 35:453-461.
2. Chui HC, Teng EL, Henderson VW, Moy AC. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985; 35:1544-1550.
3. Rossor M, Iversen L, Reynolds G. Neurochemical characteristics of early and late onset types of Alzheimer's disease. BMJ 1984;288:961-964.
4. Rossor MN. Molecular pathology of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1993;56:583-586.
5. St. George-Hyslop PH, Myers RH, Haines JL, et al. Familial Alzheimer's disease: progress and problems. Neurobiol Aging 1989;10:417-427.
6. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706.
7. Murrell J, Farlow M, Ghetti B, et al. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 1991;254:97-98.
8. Chartier-Harlin MC, Crawford F, Houlden H, et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 1991;353: 844-846.
9. Mullan M, Crawford F, Axelman K, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genet 1992;1:345-347.
10. Mullan M, Houlden H, Windelspecht M, et al. A locus for familial early onset Alzheimer's disease on the long arm of chromosome 14 proximal to the alpha 1 antichymotrypsin gene. Nature Genet 1992;2:340-343.
11. Schellenberg GD, Bird T, Wijsman E, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 1992;258:668-671.
12. St. George-Hyslop PH, Haines J, Rogaev E, et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genet 1992;2:330-334.
13. Van Broeckhoven C, Backhovens H, Cruts M, et al. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3. Nature Genet 1992;2:335-339.
14. Lampe TH, Bird TD, Nochlin D, et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994;36:368-378.
15. Haltia M, Viitanen M, Sulkava R, et al. Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol 1994;36:362-367.
16. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, et al. Linkage studies in familial Alzheimer's disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-1050.
17. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
18. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
19. Poirier J, Davignon J, Bouthillier D, Kogan S, Betrand P, Gauthier S. Apolipoprotein polymorphism and Alzheimer's disease. Lancet 1993;342:697-699.
20. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ∈4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34:752-754.
21. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
22. Utermann G, Kindermann I, Kaffarnik H, Steinmetrz A. Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet 1984;65:232-236.
23. Menzel HJ, Kladetzky RG, Assmann G. Apolipoprotein E polymorphism and coronary heart disease. Atherosclerosis 1983;3:310-315.
24. Ignatius MJ, Gebicke-Harter PJ, Skene JHP, et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc Natl Acad Sci USA 1986;83:1125-1129.
25. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res 1991;541:163-166.
26. Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992;135:235-238.
27. Breitner JCS, Folstein MF. Familial Alzheimer dementia: a prevalent disorder with specific clinical features. Psychol Med 1984;14:63-80.
28. Luchins DJ, Cohen D, Hanrahan P, et al. Are there clinical differences between familial and nonfamilial Alzheimer's disease? Am J Psychiatry 1992;149:1023-1027.
29. Edwards JK, Larson EB, Hughes JP, Kukull WA. Are there clinical and epidemiological differences between familial and non-familial Alzheimer's disease? J Am Geriatr Soc 1991;39: 477-483.
30. Nee LE, Polinsky RJ, Eldridge R, Weingartner H, Smallberg S, Ebert M. A family with histologically confirmed Alzheimer's disease. Arch Neurol 1983;40:203-208.
31. Haupt M, Kurz A, Pollmann S, Romero B. Alzheimer's disease: identical phenotype of familial and non-familial cases. J Neurol 1992;239:248-250.
32. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
33. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-198.
34. Reisberg B, Schneck MK, Ferris SH. The brief cognitive rating scale (BCRS): findings in primary degenerative dementia (PDD). Psychopharmacol Bull 1983;19:734-739.
35. Webster DD. Clinical analysis of the disability on Parkinson's disease. Mod Treat 1968;5:257-262.
36. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
37. Rosen WG, Terry RD, Fuld PA, Katzman R, Beck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
38. Helkala E-L, Laulumaa V, Soininen H, Riekkinen PJ. Recall and recognition on memory in patients with Alzheimer's and Parkinson's diseases. Ann Neurol 1988;24:214-217.
39. Wechsler D. A standardised memory scale for clinical use. J Psychol 1945;19:87-95.
40. Russell EW. A multiple scoring method for assessment of complex memory functions. J Consult Clin Psychol 1975;43:800-809.
41. Kaplan E, Goodglass H, Weintraub S. The Boston naming test. Philadelphia: Lea and Febiger, 1983.
42. Wechsler D. WAIS-R manual. New York: Psychological Corporation, 1981.
43. Goodglass H, Kaplan E. The assessment of aphasia and related disorders. Philadelphia: Lea and Febiger, 1983.
44. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976;12:313-324.
45. Reitan RM. Validity of the Trail Making test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271-276.
46. Borkowski JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia 1967;5:135-140.
47. Hixon JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 1990;31:545-548.
48. Tsukamoto K, Watanabe T, Matsushima T, et al. Determination by PCR-RFLP of apoE genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.
49. Lehtovirta M, Laakso MP, Soininen H, et al. Volumes of hippocampus, amygdala, and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience 1995; 67:65-72.
50. Heyman A, Wilkinson WE, Hurwitz BJ, et al. Alzheimer's disease: genetic aspects and associated clinical disorders. Ann Neurol 1983;14:507-515.
51. Folstein MD, Breitner JCS. Language disorders predicts familial Alzheimer's disease. Johns Hopkins Med J 1981;149: 145-147.
52. Kuusisto J, Koivisto K, Mykkänen L, et al. Association of apolipoprotein E phenotypes with late-onset Alzheimer's disease: a population-based study. BMJ 1994;309:636-638.
53. Lannfelt L, Lilius L, Nastase M, et al. Lack of association between apolipoprotein E allele ∈4 and sporadic Alzheimer's disease. Neurosci Lett 1994;169:175-178.
54. Tsai M-S, Tangalos EG, Petersen RC, et al. Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 1994; 54:643-649.
55. Gerdes L, Klausen I, Sihm I, Færgeman O. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155-167.
56. Eichner JE, Kuller LH, Orchard TJ, et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary heart disease. Am J Cardiol 1993;71:160-165.
57. Eto M, Watanabe K, Makino I. Increased frequencies of apolipoprotein E2 and E4 alleles in patients with ischemic heart disease. Clin Genet 1989;39:183-189.
58. Ferini-Strambi L, Smirne S, Garancini P, Pinto P, Franceschi M. Clinical and epidemiological aspects of Alzheimer's disease with presenile onset: a case control study. Neuroepidemiology 1990;9:39-49.
59. Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990;47:847-850.
60. Sulkava R. Alzheimer's disease and senile dementia of Alzheimer type. A comparative study. Acta Neurol Scand 1982;65: 636-650.
61. Mölsä PK, Marttila RJ, Rinne UK. Extrapyramidal signs in Alzheimer's disease. Neurology 1984;34:1114-1116.
62. Pearce J. The extrapyramidal disorder of Alzheimer's disease. Eur Neurol 1974;12:94-103.
63. Soininen H, Laulumaa V, Helkala E-L, Hartikainen P, Riekkinen PJ. Extrapyramidal signs in Alzheimer's disease: a 3-year follow-up study. J Neural Transm 1992;4:107-119.
64. Farlow M, Murrell J, Ghetti B. Clinical characteristics in a kindred with early-onset Alzheimer's disease and their linkage to a G-T change at position 2149 of the amyloid precursor protein gene. Neurology 1994;44:105-111.
65. Mullan M, Tsuji S, Miki T, et al. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val-Ile mutation in the amyloid precursor protein gene. Neurobiol Aging 1993;14:407-419.